Biotech Values

[DewDiligence]

Addendum—I would submit that ARDX’s lawsuit against Medicare is exactly the kind of case the US Supreme Court envisioned when reversing the longstanding “Chevron” doctrine of judicial deference to the interpretations of government agencies.

If ARDX were to allow CMS’s Part-D coverage decision to stand, they would probably go out of business in fairly short order.